Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo

Melissa A. Rosenfeld(National Institutes of Health), Wolfgang Siegfried(National Institutes of Health), Kunihiko Yoshimura(National Institutes of Health), Koichi Yoneyama(National Institutes of Health), Masashi Fukayama(National Institutes of Health), Larue E. Stier(National Institutes of Health), Paavo Pääkkö(National Institutes of Health), Pascale Gilardi(Institut Gustave Roussy), Leslie D. Stratford-Perricaudet(Institut Gustave Roussy), Michel Perricaudet(Institut Gustave Roussy), Sophie Jallat(Transgene (France)), Andréa Pavirani(Transgene (France)), Jean‐Pierre Lecocq(Transgene (France)), Ronald G. Crystal(National Institutes of Health)
Science
April 19, 1991
Cited by 743

Abstract

The respiratory epithelium is a potential site for somatic gene therapy for the common hereditary disorders alpha 1-antitrypsin (alpha 1AT) deficiency and cystic fibrosis. A replication-deficient adenoviral vector (Ad-alpha 1AT) containing an adenovirus major late promoter and a recombinant human alpha 1AT gene was used to infect epithelial cells of the cotton rat respiratory tract in vitro and in vivo. Freshly isolated tracheobronchial epithelial cells infected with Ad-alpha 1AT contained human alpha 1AT messenger RNA transcripts and synthesized and secreted human alpha 1AT. After in vivo intratracheal administration of Ad-alpha 1AT to these rats, human alpha 1AT messenger RNA was observed in the respiratory epithelium, human alpha 1AT was synthesized and secreted by lung tissue, and human alpha 1AT was detected in the epithelial lining fluid for at least 1 week.


Related Papers

No related papers found

Powered by citation graph analysis